Pfizer and BioNTech will soon ask the Food and Drug Administration for emergency authorization of Covid booster doses for that age group, the companies said.
Author: SHARON LaFRANIERE
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}